Fermented Maillard Reaction Products by Lactobacillus gasseri 4M13 Alters the Intestinal Microbiota and Improves Dysfunction in Type 2 Diabetic Mice with Colitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Yu-Jin | - |
dc.contributor.author | Park, Ho-Young | - |
dc.contributor.author | Nam, Han-Kyul | - |
dc.contributor.author | Lee, Kwang-Won | - |
dc.date.accessioned | 2021-11-22T04:40:40Z | - |
dc.date.available | 2021-11-22T04:40:40Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2021-04 | - |
dc.identifier.issn | 1424-8247 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/128315 | - |
dc.description.abstract | Inflammatory bowel disease is a chronic relapsing disease. Multiple factors can cause inflammatory bowel disease (IBD), including diet, imbalance of the immune system, and impaired intestinal barrier function. Type 2 diabetes mellitus is a complex and chronic metabolic disease caused by a combination of insulin resistance and an ineffective insulin secretory response. The co-occurrence of these two diseases, demonstrating interrelated effects within the gut microbiota, has been frequently reported. This study evaluated the effects of a fermented glycated conjugate of whey protein and galactose with Lactobacillus gasseri 4M13 (FMRP) to prevent type 2 diabetes mellitus with inflammatory bowel disease. C57BLKS/J- db/db mice were orally administered FMRP for 14 consecutive days and 2% dextran sulfate sodium (DSS) in water ad libitum for 5 days to induce colitis. FMRP-fed mice showed improved insulin secretion and symptoms of colitis. Compared to the DSS group, the FMRP group showed a decreased abundance of six bacterial genera and increased abundance of Alistipes and Hungateiclostridium. In cecal contents, the levels of short-chain fatty acids increased in the FMRP group compared to those in the DSS group. Continuous administration of FMRP thus may improve the homeostasis of not only insulin secretion and inflammation, but also the intestinal environment in inflammatory bowel disease and type 2 diabetes mellitus. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | INFLAMMATORY-BOWEL-DISEASE | - |
dc.subject | CHAIN FATTY-ACIDS | - |
dc.subject | GUT MICROBIOTA | - |
dc.subject | GEN. NOV. | - |
dc.subject | PATHOGENESIS | - |
dc.subject | BACTERIUM | - |
dc.subject | MELLITUS | - |
dc.subject | RISK | - |
dc.subject | FOOD | - |
dc.title | Fermented Maillard Reaction Products by Lactobacillus gasseri 4M13 Alters the Intestinal Microbiota and Improves Dysfunction in Type 2 Diabetic Mice with Colitis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kwang-Won | - |
dc.identifier.doi | 10.3390/ph14040299 | - |
dc.identifier.scopusid | 2-s2.0-85104025871 | - |
dc.identifier.wosid | 000643355000001 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICALS, v.14, no.4 | - |
dc.relation.isPartOf | PHARMACEUTICALS | - |
dc.citation.title | PHARMACEUTICALS | - |
dc.citation.volume | 14 | - |
dc.citation.number | 4 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | INFLAMMATORY-BOWEL-DISEASE | - |
dc.subject.keywordPlus | CHAIN FATTY-ACIDS | - |
dc.subject.keywordPlus | GUT MICROBIOTA | - |
dc.subject.keywordPlus | GEN. NOV. | - |
dc.subject.keywordPlus | PATHOGENESIS | - |
dc.subject.keywordPlus | BACTERIUM | - |
dc.subject.keywordPlus | MELLITUS | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | FOOD | - |
dc.subject.keywordAuthor | inflammatory bowel disease | - |
dc.subject.keywordAuthor | type 2 diabetes mellitus | - |
dc.subject.keywordAuthor | gut microbial composition | - |
dc.subject.keywordAuthor | fermented Maillard reaction products | - |
dc.subject.keywordAuthor | biological therapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.